Read the full solicitation
Sponsor Application Deadline: 05/07/2026
This opportunity supports research to elucidate how HIV-induced immunometabolic alterations, in a host suppressed on combination antiretroviral therapy (cART-suppressed), impact the immune response and increase risk for poor outcomes due to a second, potentially long-term, infection, such as Mycobacterium tuberculosis or hepatitis B virus.
